Table 2. Heart failure aetiology*.
| *Adapted from ESC Guidelines. ARVC: arrhythmogenic right ventricular cardiomyopathy; DCM: dilated cardiomyopathy; GH: growth hormone; HCM: hypertrophic cardiomyopathy; HIV/AIDS: human immunodeficiency virus/acquired immunodeficiency syndrome; LV non-compaction: left ventricular non-compaction. | ||
| Diseased myocardium | ||
| Ischemic heart disease | Myocardial scar
Myocardial stunning/hibernation Epicardial coronary artery disease Abnormal coronary microcirculation Endothelial dysfunction |
|
| Toxics | Recreational substance abuse | Alcohol, cocaine, amphetamine, anabolic steroids. |
| Heavy metals | Copper, iron, lead, cobalt. | |
| Medications | Cytostatic drugs (e.g., anthracyclines), immunomodulating drugs (e.g., interferons monoclonal antibodies such as trastuzumab, cetuximab), antidepressant drugs, antiarrhythmics, non-steroidal anti-inflammatory drugs, anaesthetics. | |
| Radiation | ||
| Immune-mediated and inflammatory damage | Infection | Bacteria, spirochaetes, fungi, protozoa, parasites (Chagas disease), rickettsiae, viruses (HIV/AIDS). |
| Not related to infection | Lymphocytic/giant cell myocarditis, autoimmune diseases (e.g., Graves’ disease, rheumatoid arthritis, connective tissue disorders, mainly systemic lupus erythematosus), hypersensitivity and eosinophilic myocarditis (Churg–Strauss). | |
| Infiltration | Related to malignancy | Direct infiltration or metastases |
| Not related to malignancy | Amyloidosis, sarcoidosis, hemochromatosis, glycogen storage disease, lysosomal storage disease. | |
| Metabolic derangements | Hormonal | Thyroid disease, acromegaly, GH deficiency, hypercortisolaemia, Conn’s disease, Addison disease, diabetes, metabolic syndrome, phaeochromocytoma, pathologies related to pregnancy and peripartum |
| Nutritional | Deficiencies in thiamine, L-carnitine, selenium, iron, phosphates, calcium, obesity. | |
| Genetic | HCM, DCM, LV non-compaction, ARVC, restrictive cardiomyopathy, muscular dystrophies and laminopathies. | |
| Pericardial and endomyocardial pathologies | Pericardial | Constrictive pericarditis
Pericardial effusion |
| Endomyocardial | Hypereosinophilic syndrome, endomyocardial fibrosis, endomyocardial fibroelastosis. | |
| Abnormal loading conditions | ||
| Hypertension | ||
| Valve and myocardium structural defects | Acquired
Congenital |
Mitral, aortic, tricuspid and pulmonary valve diseases
Atrial and ventricular septum defects and others |
| High output states | Anaemia, sepsis, Paget’s disease, arteriovenous fistula, pregnancy | |
| Volume overload | Renal failure, iatrogenic | |
| Arrhythmias | ||
| Tachyarrhythmias | Atrial or ventricular arrhythmias | |
| Bradyarrhythmias | Sinus node dysfunctions, conduction disorders | |